Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more) Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(43)
•••
Post by Breakthorough1on Aug 01, 2023 12:27pm
104 Views
Post# 35567076

Armistice and Vaxart

Armistice and Vaxart"Shareholders of Covid-19 vaccine developer Vaxart Inc. adequately stated insider trading and scheme participation claims against Armistice Capital LLC, a hedge fund linked to Vaxart, a federal court ruled.

“Accepting the allegations in the complaint as true, the Armistice Defendants did not merely trade on material nonpublic information; they participated in an intentional scheme to manipulate the price of Vaxart shares for the purpose of selling them at an artificially inflated price,” Judge Vince Chhabria said Thursday for the US District Court for the Northern District of California.




https://news.bloomberglaw.com/securities-law/hedge-fund-armistice-must-face-vaxart-insider-trading-claims
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities